Capstone Investment Advisors
RMD icon

Capstone Investment Advisors’s ResMed RMD Stock Holding History

Capstone Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$241K – 1811
2025
Q4 		$241K Sell
1,000
-1,600
-62% -$409K ﹤0.01% 1443
2025
Q3 		$712K Buy
2,600
+300
+13% +$81.9K ﹤0.01% 1164
2025
Q2 		$593K Sell
2,300
-500
-18% -$119K ﹤0.01% 1064
2025
Q1 		$627K Sell
2,800
-1,600
-36% -$374K ﹤0.01% 1024
2024
Q4 		$1.01M Sell
4,400
-3,000
-41% -$722K ﹤0.01% 1070
2024
Q3 		$1.81M Buy
7,400
+800
+12% +$179K 0.01% 768
2024
Q2 		$1.26M Buy
6,600
+600
+10% +$122K ﹤0.01% 892
2024
Q1 		$1.19M Buy
6,000
+600
+11% +$110K ﹤0.01% 1046
2023
Q4 		$929K Buy
5,400
+4,600
+575% +$707K ﹤0.01% 1077
2023
Q3 		$118K Sell
800
-600
-43% -$108K ﹤0.01% 1922
2023
Q2 		$306K Buy
+1,400
New +$312K ﹤0.01% 1384
2023
Q1 		– Sell
-1,900
Closed -$395K – 1663
2022
Q4 		$395K Sell
1,900
-18,200
-91% -$4M ﹤0.01% 1178
2022
Q3 		$4.39M Buy
20,100
+1,200
+6% +$273K 0.03% 445
2022
Q2 		$3.96M Sell
18,900
-14,900
-44% -$3.17M 0.02% 484
2022
Q1 		$8.2M Sell
33,800
-25,700
-43% -$6.22M 0.02% 527
2021
Q4 		$15.5M Sell
59,500
-7,800
-12% -$2.02M 0.03% 496
2021
Q3 		$17.7M Buy
67,300
+55,800
+485% +$15.3M 0.04% 453
2021
Q2 		$2.83M Buy
11,500
+3,700
+47% +$778K 0.01% 906
2021
Q1 		$1.51M Sell
7,800
-13,600
-64% -$2.73M ﹤0.01% 1013
2020
Q4 		$4.55M Buy
21,400
+7,300
+52% +$1.46M 0.02% 626
2020
Q3 		$2.42M Buy
14,100
+700
+5% +$129K 0.01% 743
2020
Q2 		$2.57M Buy
+13,400
New +$2.19M 0.02% 630
2020
Q1 		– Sell
-6,700
Closed -$1.04M – 1360
2019
Q4 		$1.04M Sell
6,700
-9,900
-60% -$1.43M 0.01% 995
2019
Q3 		$2.24M Buy
16,600
+5,600
+51% +$734K 0.02% 702
2019
Q2 		$1.34M Buy
11,000
+1,100
+11% +$122K 0.01% 853
2019
Q1 		$1.03M Buy
9,900
+4,700
+90% +$485K 0.01% 799
2018
Q4 		$592K Buy
+5,200
New +$557K 0.01% 781

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capstone Investment Advisors's RMD Position: Q2 2026 in Review

Capstone Investment Advisors reduced its ResMed (RMD) stake by 25% in Q2 2026, selling an estimated $130K and leaving 1,935 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

Capstone Investment Advisors first reported a position in RMD in Q4 2015 and has held it in 21 quarters since. The position peaked at $2.33M in Q3 2016. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Capstone Investment Advisors held 1,935 shares of ResMed worth $377K as of Q2 2026.
  • Capstone Investment Advisors sold 628 ResMed shares in Q2 2026, an estimated $130K.
  • ResMed made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1354 holding.
  • Capstone Investment Advisors first reported a position in ResMed in Q4 2015 and has held it in 21 quarters since.
  • Capstone Investment Advisors's ResMed position peaked at $2.33M in Q3 2016.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.